Investor Relations SEClose
Contact Ortoma

Ortoma presenterar idag på Redeye Investor Forum Online

Publicerat 26 Jan, 2023

Ortoma AB (publ) ("Ortoma" eller "Bolaget") presenterar idag den 26 januari på Redeye Investor Forum Online, presentationen hålls klockan 15:30. Ortomas VD Linus Byström kommer att presentera Bolaget.

VD Linus Byström presenterar Ortoma och ger en uppdatering kring bolagets verksamhet och utveckling på det livesända eventet Redeye Investor Forum den 26 januari klockan 15.30. Livesändningen av eventet kan ses på Redeyes hemsida: https://www.redeye.se/events/868655/investor-forum-online-13

Presentationen kommer även finnas tillgänglig på Ortomas hemsida efter eventet.

För ytterligare information vänligen kontakta:

Ortomas vd Linus Byström eller styrelseordförande Gunnar Németh
e-post: [email protected]

About Ortoma AB (publ)
Ortoma AB develops surgical systems for the planning and positioning of implants in hip, knee and spinal surgery. The purpose of the company’s surgical system, Ortoma Treatment Solution™ (OTS) is to enable surgeons to accurately measure and plan 3D surgery for the placement of joint implants, and during surgery, to optimally position the implant in the patient. Ortoma’s surgical system is aimed at providing better patient outcomes, fewer complications and less follow-up surgeries – and thus better long-term survival rates for implants. OTS is a system that is easily integrated into the processes and routines currently used in surgery, thereby increasing efficiency. Globally, more than 7.5 million orthopedic procedures are performed each year where OTS could be used in hip, knee and spinal surgery. In Sweden, around 42,000 surgical procedures were performed last year, involving hip, knee or spinal surgery. Ortoma’s B shares are listed on Spotlight Stock Market.